Jyong Biotech MENS
NASDAQ MENS
$1.74 -0.15 (-7.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

Jyong Biotech (MENS) Common Equity (2024 - 2025)

Updated

Jyong Biotech (MENS) posted Common Equity of -$24.91 million for the quarter ended Dec 31, 2025, compared with -$36.52 million a year earlier.

Analysis

Jyong Biotech (MENS) Common Equity (2024 - 2025) Analysis & Trends

  • In prior years, Jyong Biotech's Common Equity was -$36.52 million in the year ended Dec 31, 2024 and -$34.07 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 33.88 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 81.53 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn -5.94 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn 41.98 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 50.37 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 11.69 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn 11.83 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 85.49 Bn
10 Jyong Biotech 119.37 Mn 119.37 Mn - -24.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -24.91 Mn
Jun 30, 2025 -22.47 Mn
Dec 31, 2024 -36.52 Mn
API Access

Jyong Biotech Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=MENS&period=max&api_key=YOUR_API_KEY